These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1016 related items for PubMed ID: 12384702

  • 1. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.
    Groh V, Wu J, Yee C, Spies T.
    Nature; 2002 Oct 17; 419(6908):734-8. PubMed ID: 12384702
    [Abstract] [Full Text] [Related]

  • 2. Immunology: catch us if you can.
    Yokoyama WM.
    Nature; 2002 Oct 17; 419(6908):679-80. PubMed ID: 12384682
    [No Abstract] [Full Text] [Related]

  • 3. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P, Shojaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff H, Kabelitz D, Wesch D.
    Scand J Immunol; 2007 Oct 17; 66(2-3):320-8. PubMed ID: 17635809
    [Abstract] [Full Text] [Related]

  • 4. Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease.
    Azimi N, Jacobson S, Tanaka Y, Corey L, Groh V, Spies T.
    Immunogenetics; 2006 May 17; 58(4):252-8. PubMed ID: 16568261
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
    Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T.
    Science; 1999 Jul 30; 285(5428):727-9. PubMed ID: 10426993
    [Abstract] [Full Text] [Related]

  • 9. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.
    Raffaghello L, Prigione I, Airoldi I, Camoriano M, Levreri I, Gambini C, Pende D, Steinle A, Ferrone S, Pistoia V.
    Neoplasia; 2004 Jul 30; 6(5):558-68. PubMed ID: 15548365
    [Abstract] [Full Text] [Related]

  • 10. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.
    Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T.
    Nat Immunol; 2001 Mar 30; 2(3):255-60. PubMed ID: 11224526
    [Abstract] [Full Text] [Related]

  • 11. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.
    Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, Spies T.
    Immunogenetics; 2001 Mar 30; 53(4):279-87. PubMed ID: 11491531
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.
    Kaiser BK, Yim D, Chow IT, Gonzalez S, Dai Z, Mann HH, Strong RK, Groh V, Spies T.
    Nature; 2007 May 24; 447(7143):482-6. PubMed ID: 17495932
    [Abstract] [Full Text] [Related]

  • 14. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M.
    FASEB J; 2013 Jun 24; 27(6):2440-50. PubMed ID: 23395909
    [Abstract] [Full Text] [Related]

  • 15. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    Wiemann K, Mittrücker HW, Feger U, Welte SA, Yokoyama WM, Spies T, Rammensee HG, Steinle A.
    J Immunol; 2005 Jul 15; 175(2):720-9. PubMed ID: 16002667
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.